Comparative efficacy and safety of infliximab and its biosimilars in patients with rheumatoid arthritis presenting an insufficient response to methotrexate-Reference-Cited by-同舟云学术

Comparative efficacy and safety of infliximab and its biosimilars in patients with rheumatoid arthritis presenting an insufficient response to methotrexate

Published:2021-07-06 Issue: Volume: Page:
ISSN:0340-1855
Container-title:Zeitschrift für Rheumatologie
language:en
Short-container-title:Z Rheumatol

Author:

Lee Young Ho^ORCID,Song Gwan Gyu

Publisher

Springer Science and Business Media LLC

Subject

Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s00393-021-01040-0.pdf

Reference28 articles.

1. Kim H, Sung Y‑K (2021) Epidemiology of rheumatoid arthritis in Korea. J Rheum Dis 28:60–67

2. Lee YH, Song GG (2020) Circulating interleukin-37 levels in rheumatoid arthritis and systemic lupus erythematosus and their correlations with disease activity: a meta-analysis. J Rheum Dis 27:152–158

3. Lee YH, Song GG (2019) Causal association between rheumatoid arthritis with the increased risk of type 2 diabetes: a mendelian randomization analysis. J Rheum Dis 26:131–136

4. Maini RN, Breedveld FC, Kalden JR et al (2004) Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. Arthritis Rheum 50:1051–1065

5. Simoens S, Jacobs I, Popovian R, Isakov L, Shane LG (2017) Assessing the value of biosimilars: a review of the role of budget impact analysis. PharmacoEconomics 35:1047–1062

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-TNFα in inflammatory bowel disease: from originators to biosimilars;Frontiers in Pharmacology;2024-07-24

2. Infliximab biosimilar GP1111: a review of 5 years’ post-approval experience;Expert Opinion on Biological Therapy;2024-07-02

3. Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis;Journal of Personalized Medicine;2022-02-25